![]() 001060 5 months ago | Other | ₩450 Per Share |
![]() 001060 27 Dec 2023 | Other | ₩400 Per Share |
![]() 001060 28 Dec 2022 | Other | ₩356.94 Per Share |
![]() 001060 29 Dec 2021 | Other | ₩309.35 Per Share |
![]() 001060 29 Dec 2020 | Other | ₩291.59 Per Share |
30 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | - Cons. EPS | 675.23 EPS |
3 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
7 Aug 2024 Date | | 527.05 Cons. EPS | - EPS |
![]() 001060 5 months ago | Other | ₩450 Per Share |
![]() 001060 27 Dec 2023 | Other | ₩400 Per Share |
![]() 001060 28 Dec 2022 | Other | ₩356.94 Per Share |
![]() 001060 29 Dec 2021 | Other | ₩309.35 Per Share |
![]() 001060 29 Dec 2020 | Other | ₩291.59 Per Share |
30 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
6 May 2025 Date | | - Cons. EPS | 675.23 EPS |
3 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
7 Aug 2024 Date | | 527.05 Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Young-Sub Shin CEO | KRX SM Exchange | KR7001060003 ISIN |
KR Country | 1,048 Employees | - Last Dividend | 27 Dec 2023 Last Split | - IPO Date |
JW Pharmaceutical Corporation operates both within Japan and internationally, engaging in the manufacturing and distribution of medicines and medical supplies. Since its inception in 1945, the company has grown to become a vital player in the healthcare industry, providing a wide range of products aimed at improving the health and well-being of its customers. Based in Gwacheon-si, South Korea, JW Pharmaceutical Corporation has dedicated itself to addressing various medical needs, spanning from critical areas such as cancer and immunological diseases to general health and beauty care.
The core of JW Pharmaceutical Corporation's product line focuses on the development and distribution of treatments for major health concerns, including cancer, immunological diseases, cardiovascular and metabolic diseases, regenerative medicine, eye diseases, and specifically pancreatic cancer. Through intensive research and development, the company strives to bring innovative medicines to the market, hoping to improve patient outcomes in these critical areas.
Beyond pharmaceuticals, JW Pharmaceutical Corporation offers a range of medical equipment designed to support healthcare professionals. This includes infant care systems for the youngest patients, gynecological examining tables for women's health, a variety of operating room equipment for surgical needs, and steam sterilizers for ensuring the sterility of medical tools and environments.
Addressing the everyday health and wellness needs of individuals, JW Pharmaceutical Corporation has also developed products focusing on wound care, pain management, and beauty care. These products aim to enhance the quality of life for their users by providing relief and support for common health and aesthetic concerns.